Q4 2024 EPS Estimates for STERIS plc (NYSE:STE) Reduced by Analyst

STERIS plc (NYSE:STE) – Stock analysts at Zacks Research dropped their Q4 2024 earnings estimates for shares of STERIS in a research note issued on Thursday, May 2nd. Zacks Research analyst R. Department now expects that the medical equipment provider will post earnings of $2.41 per share for the quarter, down from their prior forecast of $2.42. The consensus estimate for STERIS’s current full-year earnings is $8.67 per share. Zacks Research also issued estimates for STERIS’s Q1 2025 earnings at $2.16 EPS and Q2 2026 earnings at $2.55 EPS.

STERIS (NYSE:STE) last released its quarterly earnings results on Wednesday, February 7th. The medical equipment provider reported $2.22 earnings per share for the quarter, topping the consensus estimate of $2.17 by $0.05. The firm had revenue of $1.40 billion for the quarter, compared to analysts’ expectations of $1.35 billion. STERIS had a net margin of 10.48% and a return on equity of 13.67%. The business’s quarterly revenue was up 14.8% on a year-over-year basis. During the same quarter in the prior year, the firm posted $2.02 earnings per share.

Several other research firms also recently commented on STE. StockNews.com downgraded shares of STERIS from a “buy” rating to a “hold” rating in a research note on Friday. Stephens reaffirmed an “overweight” rating and set a $250.00 price objective on shares of STERIS in a research note on Friday, February 9th. TheStreet raised STERIS from a “c+” rating to a “b” rating in a research note on Wednesday, February 7th. JMP Securities restated a “market outperform” rating and set a $265.00 price target on shares of STERIS in a research report on Thursday, February 8th. Finally, KeyCorp assumed coverage on STERIS in a research report on Tuesday, February 6th. They issued an “overweight” rating and a $253.00 price objective for the company. Four analysts have rated the stock with a hold rating and three have issued a buy rating to the company. According to data from MarketBeat, the company presently has an average rating of “Hold” and a consensus price target of $239.60.

STERIS Price Performance

Shares of NYSE:STE opened at $209.52 on Monday. STERIS has a one year low of $185.22 and a one year high of $254.00. The company has a debt-to-equity ratio of 0.50, a current ratio of 2.43 and a quick ratio of 1.49. The firm has a market capitalization of $20.70 billion, a price-to-earnings ratio of 36.69 and a beta of 0.81. The company’s fifty day moving average price is $217.97 and its 200-day moving average price is $216.04.

Institutional Inflows and Outflows

Several hedge funds have recently made changes to their positions in the stock. Vanguard Group Inc. grew its stake in shares of STERIS by 0.5% during the 4th quarter. Vanguard Group Inc. now owns 11,864,606 shares of the medical equipment provider’s stock valued at $2,608,434,000 after purchasing an additional 53,526 shares during the period. Massachusetts Financial Services Co. MA increased its holdings in STERIS by 1.3% during the fourth quarter. Massachusetts Financial Services Co. MA now owns 5,811,818 shares of the medical equipment provider’s stock valued at $1,277,728,000 after buying an additional 77,152 shares during the last quarter. Northern Trust Corp raised its position in STERIS by 0.5% in the third quarter. Northern Trust Corp now owns 1,218,012 shares of the medical equipment provider’s stock worth $267,256,000 after acquiring an additional 6,101 shares during the period. Norges Bank bought a new position in STERIS in the fourth quarter worth approximately $220,954,000. Finally, Mitsubishi UFJ Asset Management Co. Ltd. grew its position in shares of STERIS by 4.8% during the 4th quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 976,402 shares of the medical equipment provider’s stock valued at $208,491,000 after acquiring an additional 44,781 shares during the period. 94.69% of the stock is owned by hedge funds and other institutional investors.

STERIS Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, June 26th. Stockholders of record on Wednesday, June 12th will be issued a dividend of $0.52 per share. This represents a $2.08 dividend on an annualized basis and a dividend yield of 0.99%. The ex-dividend date is Wednesday, June 12th. STERIS’s payout ratio is currently 36.43%.

About STERIS

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.